Hair loss and whitening of hairs observed in very rare cases
Tests carried out with GLP-1 had so far proved disappointing, leading many to question its role in glucose metabolism
Cost, patient preference, and side effects still matter, but they are all secondary to what the insurance will actually pay for. Zepbound is for adults with obesity or overweight who also have weight-related health conditions such as type 2 diabetes, cardiovascular disease, or high blood pressure
The most common thing you might notice is mild redness, tenderness, or slight swelling where the needle went in, and that usually settles quickly
The high rates of obesity and diabetes among PCOS patients receiving semaglutide and tirzepatide in this study are consistent with these metabolic features and suggest that GLP-1 RA therapy may play an expanding role in addressing the metabolic aspects of PCOS
October 30, 2025